Edmond de Rothschild Holding’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $85.3K | Hold |
191
| – | – | ﹤0.01% | 424 |
|
|
2025
Q4 | $86.6K | Hold |
191
| – | – | ﹤0.01% | 433 |
|
|
2025
Q3 | $74.8K | Hold |
191
| – | – | ﹤0.01% | 444 |
|
|
2025
Q2 | $85K | Sell |
191
-23
| -11% | -$10.6K | ﹤0.01% | 423 |
|
|
2025
Q1 | $104K | Sell |
214
-179
| -46% | -$83.4K | ﹤0.01% | 414 |
|
|
2024
Q4 | $158K | Sell |
393
-899
| -70% | -$417K | ﹤0.01% | 425 |
|
|
2024
Q3 | $601K | Buy |
1,292
+40
| +3% | +$19.2K | 0.01% | 319 |
|
|
2024
Q2 | $587K | Sell |
1,252
-202
| -14% | -$87.7K | 0.01% | 328 |
|
|
2024
Q1 | $608K | Sell |
1,454
-129
| -8% | -$54.5K | 0.01% | 345 |
|
|
2023
Q4 | $644K | Sell |
1,583
-121
| -7% | -$44.7K | 0.01% | 339 |
|
|
2023
Q3 | $593K | Sell |
1,704
-147
| -8% | -$51.4K | 0.01% | 347 |
|
|
2023
Q2 | $651K | Sell |
1,851
-30
| -2% | -$10.1K | 0.01% | 362 |
|
|
2023
Q1 | $593K | Sell |
1,881
-4,646
| -71% | -$1.39M | 0.01% | 365 |
|
|
2022
Q4 | $1.88M | Buy |
6,527
+308
| +5% | +$93.9K | 0.04% | 254 |
|
|
2022
Q3 | $1.8M | Sell |
6,219
-6,867
| -52% | -$1.98M | 0.05% | 250 |
|
|
2022
Q2 | $3.69M | Sell |
13,086
-4,643
| -26% | -$1.24M | 0.09% | 189 |
|
|
2022
Q1 | $4.63M | Sell |
17,729
-2,310
| -12% | -$548K | 0.1% | 174 |
|
|
2021
Q4 | $4.4M | Sell |
20,039
-5,677
| -22% | -$1.1M | 0.1% | 185 |
|
|
2021
Q3 | $4.67M | Sell |
25,716
-2,061
| -7% | -$402K | 0.11% | 177 |
|
|
2021
Q2 | $5.6M | Buy |
27,777
+506
| +2% | +$106K | 0.13% | 157 |
|
|
2021
Q1 | $5.86M | Buy |
27,271
+1,943
| +8% | +$427K | 0.16% | 145 |
|
|
2020
Q4 | $5.99M | Buy |
25,328
+15,211
| +150% | +$3.49M | 0.2% | 125 |
|
|
2020
Q3 | $2.75M | Hold |
10,117
| – | – | 0.11% | 175 |
|
|
2020
Q2 | $2.94M | Buy |
10,117
+9,903
| +4,628% | +$2.68M | 0.12% | 160 |
|
|
2020
Q1 | $51K | Hold |
214
| – | – | ﹤0.01% | 456 |
|
|
2019
Q4 | $47K | Hold |
214
| – | – | ﹤0.01% | 479 |
|
|
2019
Q3 | $36K | Hold |
214
| – | – | ﹤0.01% | 487 |
|
|
2019
Q2 | $39K | Hold |
214
| – | – | ﹤0.01% | 480 |
|
|
2019
Q1 | $39K | Hold |
214
| – | – | ﹤0.01% | 494 |
|
|
2018
Q4 | $35K | Hold |
214
| – | – | ﹤0.01% | 556 |
|
|
2018
Q3 | $41K | Hold |
214
| – | – | ﹤0.01% | 617 |
|
|
2018
Q2 | $36K | Hold |
214
| – | – | ﹤0.01% | 633 |
|
|
2018
Q1 | $35K | Sell |
214
-11,600
| -98% | -$1.89M | ﹤0.01% | 655 |
|
|
2017
Q4 | $1.77M | Sell |
11,814
-14,150
| -54% | -$2.1M | 0.05% | 214 |
|
|
2017
Q3 | $3.95M | Sell |
25,964
-129,400
| -83% | -$19.5M | 0.11% | 142 |
|
|
2017
Q2 | $20M | Sell |
155,364
-50,000
| -24% | -$6.02M | 0.56% | 52 |
|
|
2017
Q1 | $22.5M | Sell |
205,364
-36,500
| -15% | -$3.21M | 0.6% | 52 |
|
|
2016
Q4 | $17.8M | Buy |
241,864
+26,000
| +12% | +$2.12M | 0.49% | 62 |
|
|
2016
Q3 | $18.8M | Sell |
215,864
-9,200
| -4% | -$869K | 0.57% | 55 |
|
|
2016
Q2 | $19.4M | Buy |
225,064
+36,550
| +19% | +$3.16M | 0.62% | 44 |
|
|
2016
Q1 | $15M | Buy |
188,514
+58,300
| +45% | +$5.27M | 0.48% | 61 |
|
|
2015
Q4 | $16.4M | Buy |
130,214
+15,000
| +13% | +$1.81M | 0.44% | 64 |
|
|
2015
Q3 | $12M | Buy |
115,214
+115,000
| +53,738% | +$14.8M | 0.3% | 78 |
|
|
2015
Q2 | $26K | Buy |
+214
| New | +$27K | ﹤0.01% | 706 |
|
Other funds holding VRTX
VCM
VPM
Edmond de Rothschild Holding's VRTX Position: Q1 2026 in Review
Edmond de Rothschild Holding held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 191 shares worth $85.3K. The position accounts for ﹤0.01% of the portfolio, ranked #424.
Edmond de Rothschild Holding first reported a position in VRTX in Q2 2015 and has held it in 44 quarters since. The position peaked at $22.5M in Q1 2017. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Edmond de Rothschild Holding held 191 shares of Vertex Pharmaceuticals worth $85.3K as of Q1 2026.
- Edmond de Rothschild Holding left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
- Vertex Pharmaceuticals made up ﹤0.01% of Edmond de Rothschild Holding's portfolio in Q1 2026, its #424 holding.
- Edmond de Rothschild Holding first reported a position in Vertex Pharmaceuticals in Q2 2015 and has held it in 44 quarters since.
- Edmond de Rothschild Holding's Vertex Pharmaceuticals position peaked at $22.5M in Q1 2017.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Edmond de Rothschild Holding's 13F filing for Q1 2026, filed 13 May 2026.